Showing results (31-40 of 195) with videos related to
Sort By:
Pageof 20
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 19, 2019
Patient Preferences for Endobronchial Valve Treatment of Severe EmphysemaCarol Mansfield, Jessie Sutphin, Kelly Shriner, et al.Respiratory Research|August 8, 2012
Longitudinal inspiratory capacity changes in chronic obstructive pulmonary diseaseBartolome R Celli, Marc Decramer, Theodore Lystig, et al.American Journal of Physical Medicine & Rehabilitation|February 17, 2007
Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPDHildegarde Paz-Díaz, Maria Montes de Oca, Jose M López, et al.Journal of Medical Economics|September 12, 2015
Exacerbations, health services utilization, and costs in commercially-insured COPD patients treated with nebulized long-acting β2-agonistsYaozhu J Chen, Charles Makin, Vamsi K Bollu, et al.Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Effects of Tiotropium on Exacerbations in Patients with COPD with Low or High Risk of Exacerbations: A Post-Hoc Analysis from the 4-Year UPLIFT® TrialBartolome R Celli, Marc Decramer, Guus M Asijee, et al.Respiratory Medicine|May 3, 2011
Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPDBartolome R Celli, Donald P Tashkin, Stephen I Rennard, et al.American Journal of Respiratory and Critical Care Medicine|April 10, 2010
Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndromeJose M Marin, Joan B Soriano, Santiago J Carrizo, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|December 9, 2003
Deep breath reversal and exponential return of methacholine-induced obstruction in asthmatic and nonasthmatic subjectsAndrew C Jackson, Margaret M Murphy, John Rassulo, et al.Chest|October 4, 2012
The expanding role of biomarkers in the assessment of smoking-related parenchymal lung diseasesTracy J Doyle, Victor Pinto-Plata, Danielle Morse, et al.COPD|March 22, 2012
Efficacy of tiotropium in COPD patients with FEV1 ≥ 60% participating in the UPLIFT® trialDonald P Tashkin, Bartolome R Celli, Marc Decramer, et al.Pageof 20